The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant ...

A specific graft-versus-host disease prophylaxis regimen may expand allogeneic hematopoietic stem cell transplant access to ...

When Doug Woods, a student at the University of South Carolina, swabbed his cheek at a sorority philanthropy event, he thought it was just a simple act of kindness—one that would likely go unnoticed.

New research suggests that frequent blood donation can trigger genetic changes that might protect certain stem cells from becoming cancerous. Reading time 3 minutes Your regular donation of blood ...

For years, the search for a stem cell donor has felt like a quest for a rare key-one that fits a lock with eight intricate tumblers, each representing a genetic marker.

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...

The ACCESS trial shows mismatched unrelated donors can provide excellent outcomes, addressing racial disparities in donor ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

Law, 18, was diagnosed with acute myeloid leukaemia last year and has been searching for a full stem cell donor match.

Emily Coiro works with blood cancer patients every day and knows the power of stem cell donation Wendy Grossman Kantor is an award-winning journalist who has spent 20 years as a reporter for PEOPLE.

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...